« Return to News | CROs/Service Providers

PRA Fourth Quarter Revenues Jump

Tuesday, March 6, 2007 11:00 AM

Reston, Va.-based contract research organization (CRO) PRA International reported fourth quarter revenue jumped 18.6% to $82.4 million.Income from operations in the fourth quarter totaled $6.6 million, a 48.4% decrease from $12.8 million in the year-ago quarter.

Net income was $5.7 million, or $0.23 per diluted share, compared with $7.5 million, or $0.31 per diluted share, in the fourth quarter of 2005. On Feb. 28, PRA’s shares fell 13% to $19.93.

PRA reported relatively flat revenue in 2006 and a decrease in operating income compared with last year. PRA reported 2006 service revenue of $303.2 million, compared with $294.7 in 2005.

Operating income in 2006 totaled $33.2 million compared with $51.2 million. The company’s operating margin for 2006 was 10.9%, compared with 17.4% in 2005.

“This is both an exciting and challenging time for PRA, as we are taking immediate actions aimed at getting PRA back on the path to accelerated growth,” said Terry Bieker, chief executive officer of PRA.

The company stated that it will be restructuring into three service areas: early development, product registration, and scientific & medical affairs. PRA also announced it will close its Eaton, N.J., and Ottawa, Canada, facilities. The company stated it does not expect any reduction in staff, and certain project managers and lead CRAs will be able to work remotely.

The cost of the restructuring is expected to be $9 million, with the anticipated annual savings expected to be approximately $4 million.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.